Barinthus Biotherapeutics plc. financial data

Symbol
BRNS on Nasdaq
Location
Germantown, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 827% % -18%
Debt-to-equity 25% % 48%
Return On Equity -70% % -105%
Return On Assets -56% % -91%
Operating Margin -454% % 96%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40,830,353 shares 1.5%
Common Stock, Shares, Outstanding 40,827,263 shares 3.2%
Entity Public Float $31,100,000 USD -61%
Common Stock, Value, Issued $1,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 40,661,118 shares 3.2%
Weighted Average Number of Shares Outstanding, Diluted 40,661,118 shares 3.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $0 USD -100%
Research and Development Expense $29,943,000 USD -26%
General and Administrative Expense $36,243,000 USD -9.9%
Operating Income (Loss) $82,380,000 USD -28%
Nonoperating Income (Expense) $6,319,000 USD 8.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $76,061,000 USD -29%
Income Tax Expense (Benefit) $115,000 USD 87%
Net Income (Loss) Attributable to Parent $75,878,000 USD -31%
Earnings Per Share, Basic -1 USD/shares -27%
Earnings Per Share, Diluted -1 USD/shares -27%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $74,272,000 USD
Other Assets, Current $663,000 USD 43%
Assets, Current $86,781,000 USD -36%
Property, Plant and Equipment, Net $4,519,000 USD -58%
Operating Lease, Right-of-Use Asset $2,063,000 USD -72%
Intangible Assets, Net (Excluding Goodwill) $14,909,000 USD -34%
Goodwill $0 USD -100%
Assets $109,201,000 USD -42%
Accounts Payable, Current $698,000 USD -77%
Liabilities, Current $10,798,000 USD -28%
Deferred Income Tax Liabilities, Net $320,000 USD -30%
Operating Lease, Liability, Noncurrent $9,553,000 USD -11%
Other Liabilities, Noncurrent $1,461,000 USD 3.9%
Liabilities $24,640,000 USD -16%
Retained Earnings (Accumulated Deficit) $293,002,000 USD -35%
Stockholders' Equity Attributable to Parent $84,465,000 USD -47%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $84,561,000 USD -47%
Liabilities and Equity $109,201,000 USD -42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $14,902,000 USD -26%
Net Cash Provided by (Used in) Financing Activities $2,000,000 USD 298%
Net Cash Provided by (Used in) Investing Activities $5,000 USD 98%
Common Stock, Shares Authorized 40,827,263 shares 3.2%
Common Stock, Shares, Issued 40,827,263 shares 3.2%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $11,821,000 USD 2.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $75,674,000 USD -29%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $30,830,000 USD 23%
Deferred Tax Assets, Gross $40,643,000 USD 12%
Operating Lease, Liability $11,570,000 USD -8.7%
Depreciation $3,100,000 USD 15%
Payments to Acquire Property, Plant, and Equipment $5,000 USD -98%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $76,195,000 USD -80%
Lessee, Operating Lease, Liability, to be Paid $14,812,000 USD -12%
Property, Plant and Equipment, Gross $16,793,000 USD 8.3%
Operating Lease, Liability, Current $2,017,000 USD 1.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,047,000 USD 1.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,023,000 USD 1.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) $22,000 USD 41%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,242,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,073,000 USD 1.5%
Deferred Tax Assets, Operating Loss Carryforwards $26,040,000 USD 10%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,099,000 USD 1.5%
Operating Lease, Payments $478,000 USD 38%
Additional Paid in Capital $393,248,000 USD 0.35%
Amortization of Intangible Assets $3,200,000 USD 0%
Depreciation, Depletion and Amortization $2,034,000 USD 42%
Deferred Tax Assets, Net of Valuation Allowance $9,813,000 USD -12%
Share-based Payment Arrangement, Expense $527,000 USD -89%
Interest Expense $12,000 USD